Scouting report · TNDM

Leigh A. Vosseller

Tandem's CFO since January 2018; joined as VP Finance in 2013

Born / age
(53)
Role
EVP, Chief Financial Officer & Treasurer
In the role
9 yr
Education
BS Missouri State University
Front Office rank
not ranked yet
TNDM
Tandem Diabetes Care, Inc.Medtech
Title
EVP, Chief Financial Officer & Treasurersrc
In role
since 2018-01 (9 yr)
Stake value—no holding or price on file
—thin record

Scouting sheetas of 24 Sep 2026

Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design67revenue, strategic, ebitda, relative tsr, time only · 97.3% for · company lost money
Skin in the game—no holding or price on file
—Hit rate
—Pay at risk
97%Say-on-pay
—Airtime on calls
Beat
0
Met
0
Missed
0
Withdrawn
0
Still open
0
Answers on calls
0
Questions dodged
0
Dodges / 100 answers
—

Personal and ownership data

Full name
Leigh A. Vosseller
Age
53src
Education
BS Accounting, Missouri State Universitysrc

Not on file yet: born, place of birth, citizenship, marital status.

Shares held
64,991 TNDM, 2026-03-16src
Traded, 12 months
bought $0, sold $0src
Last pay
$2.2m 2025src
Say-on-pay vote
97.3% forsrc

What to weigh

Red flag 1

  • The CFO reports to her domestic partner, the CEO. It is disclosed and controlled (compensation committee sets both packages, audit committee added controls), but the two financial-reporting certifiers share a householdsrc

Watch 2

  • The 2025 bonus paid 87% of target although worldwide revenue ($1.015bn) missed the $1.054bn target and the revenue component earned 81%src
  • The May 2026 equity grant reported on Form 4 was 62,657 time-vesting RSUs, with no PSU reportedsrc

In their favour 1

  • Stock ownership guideline is 1x salary; the proxy says all executives complied or were within the phase-in, and she bought shares in the open market in 2025src

Pay

Salary and otherBonus, stock, options, incentive

  • $1.3m2023
  • $2.5m2024
  • $2.2m2025
The table
YearSalaryBonusStockOptionsIncentiveOtherTotal
2023$437k$0$708k$0$98k$8k$1.3msrc
2024$450k$0$1.8m$0$240k$7k$2.5msrc
2025$486k$0$1.4m$0$269k$8k$2.2msrc
Bonus pays on
Cash bonus, target 60% of salary: 80% worldwide revenue vs $1.054bn target, 10% product launches, 10% customer satisfaction KPI; paid 87% of target
Long-term award pays on
2025 LTI half PSUs (50% FY2027 adjusted EBITDA margin, 50% 2025-27 TSR percentile vs the Russell 3000) and half RSUs over 36 months; May 2026 Form 4 grant was RSUs onlysrc
  • Pay at risk not on file
  • Pays on returns revenue, strategic, ebitda, relative tsr, time only
  • Shareholder vote 97.3% for
  • Pay vs profit company lost money

Career

  1. 2018 – now
    Tandem Diabetes Caresrc
    EVP, Chief Financial Officer & Treasurer (EVP since June 2018)
    Also responsible for information technology. Salary raised from $345,000 to $386,250 effective 2018-06-18 (8K-2018-06-15)
  2. 2018 – 2018
    Tandem Diabetes Caresrc
    SVP, Chief Financial Officer & Treasurer (from 2018-01-01)
  3. 2017 – 2017
    Tandem Diabetes Caresrc
    SVP, Finance (from August 2017)
  4. 2013 – 2017
    Tandem Diabetes Caresrc
    VP, Finance
  5. 2011 – 2013
    Genoptixsrc
    VP & Chief Financial Officer
    The 2018 proxy calls it 'Genoptix, fka Novartis company'
  6. 2008 – 2011
    Genoptix, Inc.src
    Finance roles before becoming CFO (titles not stated)
    Before Genoptix she held a senior finance position at Biosite Incorporated, helping build its infrastructure for international expansion; years not stated

Not located: Months of the 2013 move from Genoptix to Tandem not stated; the Biosite years and anything earlier not located in any source searched

The promise ledger

No promise on the record yet: the research routine has not scored this company's guidance.

Background

  • Family She and the CEO, John Sheridan, are in a personal relationship and share a primary residence; disclosed since the 2019 CEO succession. She reports to him, neither sets the other's pay, and the audit committee added internal controlssrc
  • Giving Director and treasurer of Girls Inc. of San Diego, a non-profit running STEM programmes for underserved girls, since January 2021src
  • Legal Named defendant with the CEO in Lowe v. Tandem Diabetes Care (S.D. Cal., filed 2023-09-08) over 2022 sales trends and forecasts; dismissed with prejudice on 2024-06-04 after the plaintiffs did not amendsrc
  • Other The proxy reports no Item 401(f) legal proceedings for any director or executive officersrc

Sources11